US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 0.230
  • -0.009-3.56%
Close Dec 20 16:00 ET
  • 0.233
  • +0.003+1.39%
Post 20:01 ET
12.69MMarket Cap-0.09P/E (TTM)

Marinus Pharmaceuticals Key Stats

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.484M--
--2024/Q4-- / 10.335M--
--2024/Q38.541M / 9.422M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.484M--
--2024/Q4-- / 10.335M--
--2024/Q38.541M / 9.422M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--

Unlock Free Earnings Estimates

Marinus Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Buy

  • Buy

    42.86%
  • Hold

    57.14%
  • Sell

    0.00%

Price Target

No Data